In conclusion, our data demonstrate that myoferlin and a minidysferlin can compensate for dysferlin-deficiency in an in vitro assay of sarcolemmal repair but not for the defects in muscle in vivo that lead to muscular dystrophy associated with the absence of dysferlin. This evidence concerns the gene MYOF and muscular dystrophy.